Who We Fund
Since 1949, LLS has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Justine Kahn
pediatric leukemia and lymphoma
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Suman Paul
T cell cancers and immunotherapy
Jennifer Amengual
lymphomas after transplant
Jenny Wang
AML
Liran Shlush
pre-leukemia
Daniel Lucas
bone marrow and leukemia biology
Logan Spector
childhood leukemia epidimiology
Stacie Dusetzina
Equity in Access
Julia Maxson
AML
Tycel Phillips
Mantle Cell Lymphoma
Bingyi Chen
AML immunotherapy
Mendel Goldfinger
MDS/AML trials for the elderly
Adam de Smith
pediatric ALL and Down Syndrome
Fenghuang Zhan
Myeloma and bone disease
Stephen Gottschalk
pediatric leukemia and CAR-T
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Paolo Strati
Non-Hodgkin Lymphoma
Catherine Bollard
pediatric blood cancers and immunotherapy
Jalpa Doshi
Equity in Access
Trent Hall
MDS
Grant Challen
preleukemia, leukemia
ImCheck Therapeutics
immunotherapy, AML
Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial
Michaela Reagan
Multiple Myeloma
Ana Vujovic
AML
Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL
Roland Walter
Antibody-based AML therapies
Coleman Lindsley
AML/MDS
Reina Takeda
AML
John Leonard
lymphoma research
Jeetayu Biswas
splicing in myeloid diseases
Tomasz Skorski
myeloproliferative neoplasms, AML
Ari Melnick
epigenetics and lymphoma
William Matsui
Myeloma
Jing Fu
myeloma
Maximilian Stahl
AML immunotherapy
Paolo Caimi
CAR-T clinical trial for CLL
Christopher Porter
Leukemia, lymphoma
Timothy Graubert
AML and MDS biology
John DiPersio
trispecific antibody for AML and MDS
Steven Park
follicular lymphoma
Nataly Cruz-Rodriguez
T-ALL and metabolism
Alfred Garfall
myeloma immunotherapy
Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia
James Rubenstein
Lymphoma of the Central Nervous System
Michael Green
lymphoma biology
Anthony Letai
improving CAR-T
Jayna Mistry
aging and leukemias
Raymond Mailhot
Equity in Access
Gianpietro Dotti
CAR T and AML
Ravindra Majeti
preleukemia, AML
Ruben Carrasco
Myeloma
Dane Vassiliadis
blood cancer biology
Huda Salman
CMML
Thomas Kipps
Hairy Cell Leukemia
Carl June
CAR T immunotherapy
Mark Dawson
B-ALL and CAR-T resistance
Eirini Papapetrou
blood cancer stem cells
Robert Soiffer
transplantation
Martin Dreyling
Mantle Cell Lymphoma
Christopher Flowers
clinical trial access
Jianguo Tao
Mantle Cell Lymphoma
Alieen Rowan
Adult T cell leukemia/lymphoma
Hao Jiang
DNA biology and leukemia
Sheng Li
Aging and AML
Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML
Jonathon Cohen
lymphoma clinical trial access in Georgia
Philippe Armand
follicular lymphoma
Soheil Meshinchi
pediatric AML
Urvi Shah
Diet and myeloma
Rong Lu
preleukemia, leukemia
Xu Ji
Equity in Access
Sham Mailankody
Myeloma immunotherapy clinical trials
George Daley
"off-the-shelf" CAR-T and CAR-NK
Jeffrey Magee
pediatric AML
Andrew Lane
BPDCN
Luca Busino
DLBCL
Jean Koff
Disparities in DLBCL
Suzanne Lentzsch
Myeloma
Affimed
immunotherapy, HL, PTCL
Lev Kats
myeloma and epigenetics
Jonas Jutzi
myeloproliferative neoplasms
Teresa Palomero
Peripheral T-cell Lymphoma
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM
Adam Olszewski
Follicular and marginal zone lymphoma
Michael Wang
Mantle Cell Lymphoma
Dan Landau
cancer evolution biology
Jonathan Licht
DNA biology, myeloma
F. Lennie Wong
Equity in Access
Anita Kumar
Mantle Cell Lymphoma immunotherapy
Ronald Levy
immunotherapies, COVID-19
Margaret Shipp
lymphoma biology
Peter Klein
MDS
Daniel Pollyea
AML
Lucy Godley
preleukemia
Cailin Collins
Leukemia and pre-leukemia
Thomas LeBlanc
palliative care
Bailee Kain
AML and African ancestry
Constellation Pharmaceuticals
myeloproliferative neoplasms
Kasey Leger
pediatric blood cancers
Dren Bio
immunotherapy, cytotoxic lymphomas, LGLL
Jeremy Baeten
AML
Ramon Massoni-Badosa
CLL and Richter's Syndrome
Bruno Paiva
smoldering myeloma
Alex Kentsis
pediatric leukemias
Caroline Arber
myeloma CAR-T
Courtney DiNardo
clinical trials, AML
Richard Lock
T-ALL
Carl Allen
pediatric blood cancers
Megan McNerney
AML/MDS
Christian Steidl
B-cell lymphomas
Daniel Thomas
Myelofibrosis
Sarah Tasian
pediatric leukemias
Kathleen Sakamoto
pediatric AML
Michael Keller
COVID-19, immunotherapy
Anouchka Laurent
T-cell lymphoma
Jun Qi
Myeloma
Marco Ruella
Immunotherapy for T-cell lymphoma
Ann-Kathrin Eisfeld
Racial diversity in AML
Matteo Bellone
Smoldering multiple myeloma
Jennifer Woyach
CLL trials
Meng Li
Equity in Access
Catriona Jamieson
cancer stem cell biology
Steven Horwitz
T-cell lymphomas
Andrew Hantel
Equity in Access
Rayne Rouce
Immunotherapy for pediatric, adolescent & young adult patients
Omar Abdel-Wahab
Hairy cell leukemia
Ravi Bhatia
transplantation
Srividya Swaminathan
pediatric, immunotherapy
Christopher Booth
BPDCN
H. Irene Su
Equity in Access
Daniel Herranz
T-ALL
Gaurav Goyal
Erdheim-Chester Disease
Helen Parsons
Equity in Access
Daphne Friedman
Equity in Access
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Venkata Lokesh Battula
immunotherapy and AML
Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's
Thomas Koehnke
leukemia
Kura Oncology
MLL leukemia, AML
Piers Patten
COVID-19
Jennifer Trowbridge
aging and leukemia
Armin Rashidi
gut bacteria and transplant success
Yibin Yang
Lymphoma
Mala Shanmugam
myeloma
Randall Davis
CLL
Qing Yi
Novel CAR-T
Nicola Vannini
Aging and CAR-T success
Michael Savona
MDS and leukemia
Marina Konopleva
MDS/AML metabolism
Jaehyuk Choi
T-cell lymphoma
Anushree Vichare
Equity in Access
George Vassiliou
Leukemia Prevention
Britta Will
Leukemia and pre-leukemia
Rajni Kumari
AML
Roberta Zappasodi
lymphoma, immunotherapy
Ricky Johnstone
lymphoma and myeloma
Tanya Siddiqi
clinical trial access
Mark Murakami
follicular lymphoma
Mark Hamilton
DLBCL and CAR-T
Eugenio Morelli
Myeloma
Kirk Schultz
pediatric transplantation
Hong Wen
AML
John Crispino
myelofibrosis, pediatric leukemia and Downs
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
Qingyu Luo
BPDCN
Sam Butterworth
CMML
Riccardo Dalla-Favera
lymphoma (DLBCL)
Grzegorz Nowakowski
Clinical trial access
Catherine Diefenbach
DLBCL immunology
BioInvent International
immunotherapy, indolent NHL, CTCL
Frederick Locke
lymphoma and immunotherapy
Taishi Yonezawa
AML
Takeshi Sugio
T-cell lymphoma
Rizwan Romee
Immunotherapy
Eric Pietras
AML
Siddhartha Jaiswal
preleukemia
Manyi Wei
acute megakaryoblastic leukemia
Ryvu Therapeutics
AML, MDS, Myelofibrosis
Liling Wan
AML
Peter Croucher
Multiple Myeloma
Koichi Takahashi
AML/MDS
Christian Marinaccio
MLL leukemias
Shazia Nakhoda
Equity in Access
Pooja Khandelwal
bone marrow transplantation
Pietro Genovese
transplant and AML
Sigurður Kristinsson
Smoldering myeloma
Lindsey Montefiori
pediatric leukemia
Saar Gill
AML immunotherapy
Enrico Tiacci
Hairy cell leukemia
Nirav Shah
CAR-T for lymphoma
Yan Liu
MDS
Rgenta Therapeutics
RNA-targeting, blood cancer
Matthew Frank
Lymphoma CART therapy
Jolanta Grembecka
leukemia therapeutics
Rachel Mersfelder
AMKL
Joachim Yahalom
Lymphoma
Yiman Liu
Epigenetics and leukemia
Courtney Jones
AML metabolism
Wendy Stock
T-cell ALL
Adi Nagler
Bronchiolitis obliterans after transplant
Nitin Jain
CLL
Elliot Stieglitz
CMML
Amit Verma
AML/MDS
Jake Shortt
precision therapy for aggressive lymphomas
Kerry Rogers
CLL
Sriram Sundaravel
AML stem cells
Neha Mehta-Shah
T-cell lymphoma
Jessica Stewart
Epstein-barr virus and lymphomas
Lawrence Boise
CART and myeloma
Enterome
vaccine, FL, MZL
Nizar Bahlis
Myeloma immunotherapy
Brian Walker
smoldering myeloma, MGUS
Christine Zhang
AML
Sahand Hormoz
MPN
Craig Jordan
AML
Madhav Dhodapkar
multiple myeloma immunotherapy
Noemí Puig Morón
Myeloma
Carma Bylund
Equity in Access
Nicoletta Cieri
AML and transplantation
Paola Aguilar Neuville
Primary cutaneous γδ T-cell lymphoma
Faron Pharmaceuticals
immunotherapy, MDS
Fahmin Basher
transplant and GvHD
Simona Colla
Myeloma biology
Markus Muschen
leukemia and lymphoma biology
Alexey Danilov
lymphoma
Eric Padron
CMML
Oreofe Odejide
Equity in Access
Caron Jacobson
lymphoma and immunotherapy
Michael Kharas
leukemia
Yubin Zhou
peripheral T cell lymphoma
Daisuke Nakada
preleukemia, leukemia
Brian Dalton
DNA mutations and myeloid cancers
Inhye Ahn
CLL
Robert Orlowski
(Smoldering) Multiple Myeloma
Jianhua Yu
myeloma immunotherapy
Dimericon Therapeutics
dimericons, blood cancer
Leandro Cerchietti
DLBCL
Wendy Béguelin
follicular lymphoma
Catherine Smith
leukemia
Bing Carter
p53 mutant AML
Steven Treon
Lymphomas and Waldenstrom's
Nicolas Nassar
pediatric leukemia
Jing Yang
Myeloma
Julia Paczkowska
immunobiology of Hodgkin's disease
Caner Saygin
T-ALL
Yoke Seng Lee
AML
Auron Therapeutics
degrader, AML, MDS
Keisuke Ito
blood cancer stem cells and MDS metabolism
Lori Muffly
Equity in Access
Kimberly Stegmaier
childhood blood cancers
Sergei Doulatov
Leukemias
Siegfried Janz
Myeloma immunotherapy
Ivan Odak
Non-Hodgkin's Lymphoma immunotherapy
Marc Seifert
Hairy cell leukemia
Tyler Parsons
MPN and AML
Tak Mak
Immunotherapy
Paul Beavis
immunotherapy in myeloma
Shannon Maude
Immunotherapy for ALL
Stephen Nimer
myeloid cancer biology
Solu Therapeutics
immunotherapy, CMML
